- Home
- TERN vs CEPF Comparison
TERN vs CEPF Comparison
Compare TERN & CEPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- CEPF
- Stock Information
- Founded
- TERN 2017
- CEPF 2021
- Country
- TERN United States
- CEPF United States
- Employees
- TERN N/A
- CEPF N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- CEPF Blank Checks
- Sector
- TERN Health Care
- CEPF Finance
- Exchange
- TERN Nasdaq
- CEPF Nasdaq
- Market Cap
- TERN 634.5M
- CEPF 580.3M
- IPO Year
- TERN 2021
- CEPF 2025
- Fundamental
- Price
- TERN $8.30
- CEPF $10.40
- Analyst Decision
- TERN Buy
- CEPF
- Analyst Count
- TERN 6
- CEPF 0
- Target Price
- TERN $13.99
- CEPF N/A
- AVG Volume (30 Days)
- TERN 1.0M
- CEPF 124.1K
- Earning Date
- TERN 11-11-2025
- CEPF 01-01-0001
- Dividend Yield
- TERN N/A
- CEPF N/A
- EPS Growth
- TERN N/A
- CEPF N/A
- EPS
- TERN N/A
- CEPF N/A
- Revenue
- TERN N/A
- CEPF N/A
- Revenue This Year
- TERN N/A
- CEPF N/A
- Revenue Next Year
- TERN N/A
- CEPF N/A
- P/E Ratio
- TERN N/A
- CEPF N/A
- Revenue Growth
- TERN N/A
- CEPF N/A
- 52 Week Low
- TERN $1.87
- CEPF $10.09
- 52 Week High
- TERN $8.78
- CEPF $10.65
- Technical
- Relative Strength Index (RSI)
- TERN 57.97
- CEPF N/A
- Support Level
- TERN $7.45
- CEPF N/A
- Resistance Level
- TERN $8.77
- CEPF N/A
- Average True Range (ATR)
- TERN 0.41
- CEPF 0.00
- MACD
- TERN -0.00
- CEPF 0.00
- Stochastic Oscillator
- TERN 51.36
- CEPF 0.00
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About CEPF Cantor Equity Partners IV Inc. Class A Ordinary Shares
Cantor Equity Partners IV Inc is a blank check company.